Hi,I am Dr. Shanthi.E (General & Family Physician). I will be looking into your question and guiding you through the process. Please write your question below.
What Causes Elevated Uric Acid Levels While On AKT4 For Tuberculosis?
I am suffrind from Tuberclosis The ADA test shows 62.7 Now am taking AKT 4 from last 14 days And today i did the test for serum uric acid amd it shows that its 9.2 . So can you please explain why its incresed ? Its due to anti tB drugs or what ?
Many medications have been associated with elevated uric acid levels. Pyra zinamide and ethambutol are two anti tuberculous drugs that have been reported to induce hyperuricemia. Pyrazinamide is a strong urate retention agent, causing a greater than 80% reduction in renal clearance of uric acid at a 300-mg therapeutic daily dose. The metabolite pyrazinoic acid is oxidized by xanthine oxidase and is likely responsible for the hyperuricemic effect. Hyperuricemia has been reported in 43% to 100% of patients treated with pyrazinamide (alone or in combination).6,9 Furthermore, gouty attacks have been associated with patients taking pyrazinamide. Ethambutol can also cause hyperuricemia by decreasing renal uric acid clearance, but it does so less consistently and to a lesser degree than pyrazinamide.
I find this answer helpful
You found this answer helpful
Note: For further follow up on related General & Family Physician Click here.
Disclaimer: These answers are for your information only and not intended to replace your relationship with your treating physician.
This is a short, free answer.
For a more detailed, immediate answer, try our premium service
[Sample answer]
We use cookies in order to offer you most relevant experience and using this website you acknowledge that you have already read and understood our
Privacy Policy
What Causes Elevated Uric Acid Levels While On AKT4 For Tuberculosis?
Many medications have been associated with elevated uric acid levels. Pyra zinamide and ethambutol are two anti tuberculous drugs that have been reported to induce hyperuricemia. Pyrazinamide is a strong urate retention agent, causing a greater than 80% reduction in renal clearance of uric acid at a 300-mg therapeutic daily dose. The metabolite pyrazinoic acid is oxidized by xanthine oxidase and is likely responsible for the hyperuricemic effect. Hyperuricemia has been reported in 43% to 100% of patients treated with pyrazinamide (alone or in combination).6,9 Furthermore, gouty attacks have been associated with patients taking pyrazinamide. Ethambutol can also cause hyperuricemia by decreasing renal uric acid clearance, but it does so less consistently and to a lesser degree than pyrazinamide.